Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cell Host & Microbe
|
April 13, 2023
Cross-feeding in the gut microbiome: Ecology and mechanisms
Elizabeth J Culp, Andrew L Goodman
Ecosal Plus
|
March 18, 2021
Ancient Antibiotics, Ancient Resistance
Nicholas Waglechner, Elizabeth J Culp, Gerard D Wright
Cell
|
September 25, 2024
Microbial transformation of dietary xenobiotics shapes gut microbiome composition
Elizabeth J Culp, Nora T Nelson, Andrew A Verdegaal, et al.
Nature Biotechnology
|
September 11, 2019
Hidden antibiotics in actinomycetes can be identified by inactivation of gene clusters for common antibiotics
Elizabeth J Culp, Grace Yim, Nicholas Waglechner, et al.
Nature Communications
|
October 17, 2020
GPAHex-A synthetic biology platform for Type IV-V glycopeptide antibiotic production and discovery
Min Xu, Wenliang Wang, Nicholas Waglechner, et al.
ACS Central Science
|
June 1, 2022
Phylogeny-Informed Synthetic Biology Reveals Unprecedented Structural Novelty in Type V Glycopeptide Antibiotics
Min Xu, Wenliang Wang, Nicholas Waglechner, et al.
Nature Microbiology
|
March 5, 2022
ClpP inhibitors are produced by a widespread family of bacterial gene clusters
Elizabeth J Culp, David Sychantha, Christian Hobson, et al.
Microbiology Spectrum
|
August 30, 2023
<i>Staphylococcus aureus</i> susceptibility to complestatin and corbomycin depends on the VraSR two-component system
Carmen Gómez-Arrebola, Sara B Hernandez, Elizabeth J Culp, et al.
Nature
|
February 14, 2020
Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling
Elizabeth J Culp, Nicholas Waglechner, Wenliang Wang, et al.
Genetics
|
February 26, 2020
Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development
Samuel Jacques, Almer M van der Sloot, Caroline C Huard, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cell Host & Microbe
|
April 13, 2023
Cross-feeding in the gut microbiome: Ecology and mechanisms
Elizabeth J Culp, Andrew L Goodman
Ecosal Plus
|
March 18, 2021
Ancient Antibiotics, Ancient Resistance
Nicholas Waglechner, Elizabeth J Culp, Gerard D Wright
Cell
|
September 25, 2024
Microbial transformation of dietary xenobiotics shapes gut microbiome composition
Elizabeth J Culp, Nora T Nelson, Andrew A Verdegaal, et al.
Nature Biotechnology
|
September 11, 2019
Hidden antibiotics in actinomycetes can be identified by inactivation of gene clusters for common antibiotics
Elizabeth J Culp, Grace Yim, Nicholas Waglechner, et al.
Nature Communications
|
October 17, 2020
GPAHex-A synthetic biology platform for Type IV-V glycopeptide antibiotic production and discovery
Min Xu, Wenliang Wang, Nicholas Waglechner, et al.
ACS Central Science
|
June 1, 2022
Phylogeny-Informed Synthetic Biology Reveals Unprecedented Structural Novelty in Type V Glycopeptide Antibiotics
Min Xu, Wenliang Wang, Nicholas Waglechner, et al.
Nature Microbiology
|
March 5, 2022
ClpP inhibitors are produced by a widespread family of bacterial gene clusters
Elizabeth J Culp, David Sychantha, Christian Hobson, et al.
Microbiology Spectrum
|
August 30, 2023
<i>Staphylococcus aureus</i> susceptibility to complestatin and corbomycin depends on the VraSR two-component system
Carmen Gómez-Arrebola, Sara B Hernandez, Elizabeth J Culp, et al.
Nature
|
February 14, 2020
Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling
Elizabeth J Culp, Nicholas Waglechner, Wenliang Wang, et al.
Genetics
|
February 26, 2020
Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development
Samuel Jacques, Almer M van der Sloot, Caroline C Huard, et al.
Page
of 2